Literature DB >> 22574444

Chemical constituents of the aerial parts of Scutellaria lateriflora and their alpha-glucosidase inhibitory activities.

Minpei Kuroda1, Katsura Iwabuchi, Yoshihiro Mimaki.   

Abstract

MeOH extracts of 37 herbs were tested in screening experiments for rat intestinal alpha-glucosidase. The MeOH extract of the aerial parts of Scutellaria lateriflora L. (Lamiaceae) significantly inhibited sucrase and maltase activities, using sucrose and maltase as the substrates. Enzyme inhibition guided-fractionation of the MeOH extract of S. lateriflora resulted in the isolation of a new diterpene glucoside, deacetylajugarin-IV 18-O-beta-D-glucopyranoside (1), along with 20 known phenolics (2-21). The structures of 1-21 were elucidated on the basis of MS and NMR data analyses. Baicalein (4) and baicalin (10), a glycoside of 4, showed moderate sucrase inhibitory activities at IC50 values of 14.9 and 36.3 microM, respectively, whereas luteolin (3), acteoside (16), leucosceptoside A (18), and isoacteoside (20) showed weak inhibitory activities at IC50 values of 811, 522, 727, and 443 microM, respectively. This is the first report on mammalian alpha-glucosidase inhibitory activities of S. lateriflora extract and identification of the constituents responsible for the activities. Apigenin (2), luteolin (3), 6-methoxyluteolin 4'-methyl ether (6), isoscutellarin 8-O-beta-D-glucuronide (7), luteolin 7-O-beta-D-glucuronide (9), wogonin 7-O-beta-D-glucuronide methyl ester (12), eriodictyol (13), naringenin (14), naringenin 7-O-beta-D-glucuronide (15), jionoside D (17), leucosceptoside A (18), and (+)-syringaresinol 4'-O-beta-D-glucopyranoside (21) were isolated from this plant for the first time. The inhibitory properties of S. lateriflora extract against alpha-glucosidase provide a prospect for its antidiabetic usage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22574444

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  4 in total

Review 1.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

Review 2.  Pharmacological Activity of Eriodictyol: The Major Natural Polyphenolic Flavanone.

Authors:  Zirong Deng; Sabba Hassan; Muhammad Rafiq; Hongshui Li; Yang He; Yi Cai; Xi Kang; Zhaoguo Liu; Tingdong Yan
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-12       Impact factor: 2.629

3.  Ultrasound Assisted Extraction and Characterization of Bioactives From Verbascum thapsus Roots to Evaluate Their Antioxidant and Medicinal Potential.

Authors:  Fatima Shahbaz; Naheed Akhter; Muhammad Shahid; Muhammad Riaz; Fozia Anjum; Fatma Hussain
Journal:  Dose Response       Date:  2022-05-03       Impact factor: 2.623

4.  Anti-anxiety and hypnotic effects of ethanolic and aqueous extracts of Lippia citriodora leaves and verbascoside in mice.

Authors:  Bibi Marjan Razavi; Naser Zargarani; Hossein Hosseinzadeh
Journal:  Avicenna J Phytomed       Date:  2017 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.